欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/5051/004
药品名称
Memantinhydrochlorid-neuraxpharm 20 mg Schmelztabletten
活性成分
memantine hydrochloride 20.0 mg
剂型
Orodispersible tablet
上市许可持有人
neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 40764 Langenfeld Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
许可日期
2013/09/05
最近更新日期
2020/01/29
药物ATC编码
N06DX01 memantine
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_blister_fcte_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_inner_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_oso_cv__20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_bl_fct_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_bl_initiation_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_inner_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_impack_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_outer_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_5051_Memantin_Neuraxpharm_pl_memantin_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_5051_Memantin_Neuraxpharm_spc_memantin_odt_cv_20170907_renewal
Date of last change:2024/09/06
PubAR
|
PAREN_DE 5051_Memantin
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase